TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway
- PMID: 25362856
- DOI: 10.1038/onc.2014.356
TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway
Abstract
Ten eleven translocation (TET) enzymes catalyse the oxidative reactions of 5-methylcytosine (5mC) to promote the demethylation process. The reaction intermediate 5-hydroxymethylcytosine (5hmC) has been shown to be abundant in embryonic stem cells and tissues but strongly depleted in human cancers. Genetic mutations of TET2 gene were associated with leukaemia, whereas TET1 downregulation has been shown to promote malignancy in breast cancer. Here we report that TET1 is downregulated in colon tumours from the initial stage. TET1 silencing in primary epithelial colon cells increase their cellular proliferation while its re-expression in colon cancer cells inhibits their proliferation and the growth of tumour xenografts even at later stages. We found that TET1 binds to the promoter of the DKK gene inhibitors of the WNT signalling to maintain them hypomethylated. Downregulation of TET1 during colon cancer initiation leads to repression, by DNA methylation, the promoters of the inhibitors of the WNT pathway resulting in a constitutive activation of the WNT pathway. Thus the DNA hydroxymethylation mediated by TET1 controlling the WNT signalling is a key player of tumour growth. These results provide new insights for understanding how tumours escape cellular controls.
Similar articles
-
TET1 suppresses colon cancer proliferation by impairing β-catenin signal pathway.J Cell Biochem. 2019 Aug;120(8):12559-12565. doi: 10.1002/jcb.28522. Epub 2019 Mar 1. J Cell Biochem. 2019. PMID: 30825236
-
TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells.J Exp Clin Cancer Res. 2019 Aug 9;38(1):348. doi: 10.1186/s13046-019-1334-5. J Exp Clin Cancer Res. 2019. PMID: 31399111 Free PMC article.
-
Epigenetic regulation of intestinal stem cells by Tet1-mediated DNA hydroxymethylation.Genes Dev. 2016 Nov 1;30(21):2433-2442. doi: 10.1101/gad.288035.116. Epub 2016 Nov 17. Genes Dev. 2016. PMID: 27856615 Free PMC article.
-
Multiple Functions of Ten-eleven Translocation 1 during Tumorigenesis.Chin Med J (Engl). 2016 Jul 20;129(14):1744-51. doi: 10.4103/0366-6999.185873. Chin Med J (Engl). 2016. PMID: 27411465 Free PMC article. Review.
-
Loss of 5-hydroxymethylcytosine in cancer: cause or consequence?Genomics. 2014 Nov;104(5):352-7. doi: 10.1016/j.ygeno.2014.08.017. Epub 2014 Aug 30. Genomics. 2014. PMID: 25179374 Free PMC article. Review.
Cited by
-
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.Gastroenterology. 2015 Oct;149(5):1204-1225.e12. doi: 10.1053/j.gastro.2015.07.011. Epub 2015 Jul 26. Gastroenterology. 2015. PMID: 26216839 Free PMC article. Review.
-
Tumor hypoxia: From basic knowledge to therapeutic implications.Semin Cancer Biol. 2023 Jan;88:172-186. doi: 10.1016/j.semcancer.2022.12.011. Epub 2023 Jan 2. Semin Cancer Biol. 2023. PMID: 36603793 Free PMC article. Review.
-
Advances in the DNA methylation hydroxylase TET1.Biomark Res. 2021 Oct 16;9(1):76. doi: 10.1186/s40364-021-00331-7. Biomark Res. 2021. PMID: 34656178 Free PMC article. Review.
-
Expression Patterns for TETs, LGR5 and BMI1 in Cancer Stem-like Cells Isolated from Human Colon Cancer.Avicenna J Med Biotechnol. 2019 Apr-Jun;11(2):156-161. Avicenna J Med Biotechnol. 2019. PMID: 31057717 Free PMC article.
-
Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups.J Neurooncol. 2018 Aug;139(1):33-42. doi: 10.1007/s11060-018-2845-1. Epub 2018 Mar 26. J Neurooncol. 2018. PMID: 29582271
References
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials